AnaptysBio, Inc. (ANAB)

AnaptysBio Revenue

AnaptysBio had revenue of $25.56M in the quarter ending March 31, 2026, a decrease of -7.98%. This brings the company's revenue in the last twelve months to $232.39M, up 107.73% year-over-year. In the year 2025, AnaptysBio had annual revenue of $234.60M with 157.01% growth.

• Revenue (ttm): $232.39M
• Revenue Growth: +107.73%
• P/S Ratio: 6.97
• Revenue / Employee: $2,234,500
• Employees: 104
• Market Cap: 1.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	234.60M	143.32M	157.01%
Dec 31, 2024	91.28M	74.12M	432.03%
Dec 31, 2023	17.16M	6.87M	66.78%
Dec 31, 2022	10.29M	-52.89M	-83.72%
Dec 31, 2021	63.18M	-11.83M	-15.77%
Dec 31, 2020	75.00M	67.00M	837.50%
Dec 31, 2019	8.00M	3.00M	60.00%
Dec 31, 2018	5.00M	-5.00M	-50.00%
Dec 31, 2017	10.00M	-6.68M	-40.06%
Dec 31, 2016	16.68M	-887.00K	-5.05%
Dec 31, 2015	17.57M	1.73M	10.94%
Dec 31, 2014	15.84M	10.36M	188.86%
Dec 31, 2013	5.48M	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error